Joint Formulary & PAD

Amisulpride - Behavioural and Psychological Symptoms of Dementia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
Guidelines
Off Label
Restrictions / Comments :
Important

Off-label use.

PAD Profile

ChemicalSubstance :
Amisulpride
Indication :
Behavioural and Psychological Symptoms of Dementia
Group Name :
Keywords :
Non-cognitive symptoms of dementia, BPSD, Alzheimer's Disease, aggression, antipsychotics
Brand Names Include :
Important Information :

Initiation and stabilisation (for a minimum of 1 month) by a specialist with experience in managing BPSD before any request to transfer prescribing responsibility.

Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
1

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:

Mental health specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.

Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.

Other Indications

Below are listed other indications that Amisulpride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Behavioural and Psychological Symptoms of Dementia.